We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Permits Marketing of First U.S. Test for TB Bacteria and Rifampicin Resistance

News   Jul 26, 2013

 
FDA Permits Marketing of First U.S. Test for TB Bacteria and Rifampicin Resistance
 
 
 

RELATED ARTICLES

A Way To "Fingerprint" Human Cells

News

Researchers have developed a new method to analyse data from individual human cells, which they say could be a step-change for diagnosing some of the most devastating diseases, including cancer and autoimmune disease.

READ MORE

Geneticists Identify Hundreds of Small Metabolites That Are Potential Disease Indicators

News

New research has identified hundreds of metabolites that could one day help doctors better monitor metabolite variation as an indicator of disease.

READ MORE

New Markers for Triple Negative Breast Cancer

News

Two biomarkers – a 44-gene DNA Damage Response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs) – can serve as prognostic markers in people diagnosed with triple negative breast cancer, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE